In this study, EZH2 promoted miR-497 silencing, as well as HDAC inhibitor induced miR-497 expression levels, which firstly identified that histone modification via HDACs and EZH2 are main regulators in miR-497 downregulation in esophageal cancer. The gene discussed is EZH2; the disease is esophageal cancer.